Aug 10, 2021 by Jason Hawthorne3 Things I'm looking For in Upstart's EarningsIt's not just about growth.
Aug 8, 2021 by Jason HawthorneTeladoc's Earnings Had 1 Important Metric for Both Bulls and BearsWhich story do you believe?
Aug 7, 2021 by Jason HawthorneThis Low-Risk Stock Is a Long-Term WinnerInvestors' expectations may never catch up with the company's performance.
Aug 6, 2021 by Jason HawthorneWhy Clover Health Shares Fell 39% in JulyThe company had a lot going on last month and none of it was good.
Aug 6, 2021 by Jason Hawthorne2 CEOs Who Share a Trait That Could Make You Rich Over the Long TermData doesn't lie. These leaders give you a better shot at long-term gains.
Aug 5, 2021 by Jason HawthorneWhy Shares of Intellia Therapeutics Are Jumping TodayMore progress in the pipeline has investors bullish on the company's shares.
Aug 4, 2021 by Jason Hawthorne3 Numbers That Should Shock Robinhood ShareholdersThey all point to a complicated relationship with its customers.
Aug 4, 2021 by Jason HawthorneWhy Invitae Stock Is Climbing TodayAccelerating growth is giving investors more confidence in the genetic testing company's long-term prospects.
Aug 4, 2021 by Jason Hawthorne, Rachel Warren, and Steven Ditto$5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 YearsThese companies could upend the industry in the years ahead.
Aug 3, 2021 by Jason HawthorneWhy Shares of Immunovant Are Down Almost 10% This AfternoonAn analyst note is extending yesterday's sell-off.
Aug 3, 2021 by Jason HawthorneWhy Shares of Moderna Are Up TodayA regulatory action is giving investors a glimpse of its business beyond the pandemic.
Aug 2, 2021 by Jason HawthorneWhy Shares of Immunovant Are Tanking TodayShareholders are throwing in the towel after not getting the deal they were expecting.
Aug 1, 2021 by Jason HawthorneBetter Biotech Stock: Moderna vs. BioNTechThe two companies behind the gene-based COVID vaccines are a lot different than you might think.
Jul 31, 2021 by Jason Hawthorne3 Things About Moderna That Smart Investors KnowAdd them up and you get a revolutionary company that's priced for perfection.
Jul 30, 2021 by Jason HawthorneWhy Shares of Dexcom Are Gaining This MorningWall Street is thrilled with acceleration out of the pandemic and a new product on the horizon.
Jul 30, 2021 by Jason Hawthorne2 Reasons Paycom Shareholders Shouldn't Worry About Rising Interest RatesScary headlines might be good for shareholders, no matter how the stock market reacts.
Jul 30, 2021 by Jason Hawthorne3 Things About Illumina That Smart Investors KnowThe company is cemented as the industry leader, but a crack is showing.
Jul 29, 2021 by Jason HawthorneThis Biotech Stock Is Too Cheap to IgnoreWall Street's short attention span has created an attractive entry point in this once-loved biotech.
Jul 29, 2021 by Jason HawthorneWall Street Might Be Missing This Key to Growth at Johnson & JohnsonShareholders bored by lagging returns might get some excitement in the near future.
Jul 28, 2021 by Jason HawthorneWhy Shares of Hill-Rom Holdings Jumped TodayReports of a bid for the company have lifted the stock. But there is no deal yet.
